Interactive Decision Support Tool


Share

Program Content

Activities

  • NSCLC Treatment Tool
    Interactive Decision Support Tool: Expert Insight on Therapy Selection for Unresectable Stage III and Metastatic NSCLC
    Tool
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 12, 2021

    Expires: January 11, 2022

Provided by

ProCE Banner

Supporters

This activity is supported by independent educational grants from

Bristol Myers Squibb

Celgene

Lilly

Loxo Oncology subsidiary of Eli Lilly